Combining PET and CT scans makes cancer treatment more accurate

May 01, 2006

Doctors have discovered that combining images derived from positron emission tomography and computed tomography in the planning and delivery of radiation treatment for patients with head and neck cancer leads to more accurate delivery of the radiation dose and an increased chance for survival. The study was published in the May 2006 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of ASTRO, the American Society for Therapeutic Radiology and Oncology.

The pilot study, conducted on 28 patients, set out to discern whether combining PET and CT images to plan intensity modulated radiation therapy, or IMRT, treatments for patients resulted in better delivery of the radiation and lower recurrence rates. The doctors fused images captured from both the PET and CT scans and found that the proposed treatment plans were very different in 14 of 16 patients whose plans had been designed using CT scanning alone. Out of the 28 patients who were followed for more than six months after treatment, 16 showed no signs of recurrence. The current standard of care for head and neck cancer patients involves surgery or radiation for early-stage cancer and some combination of radiation, surgery or chemotherapy for advanced cases. The high doses of radiation therapy that patients receive cause toxicity which can negatively impact a patients' quality of life. This study shows that IMRT, which modifies the intensity of the radiation beams to both the tumor and surrounding healthy tissue in order to avoid side effects while killing the cancer, can be used as an alternative to standard radiation therapy and could improve the patients' quality of life after cancer treatment.

"Even though it's a small sample group, this study shows the fusion of PET/CT can significantly improve treatment planning for radiation therapy and might ultimately help patients with head and neck cancer who receive radiation therapy beat their disease," said Dian Wang, M.D., Ph.D., lead author of the study and a radiation oncologist at the Medical College of Wisconsin in Milwaukee. "In addition, these patients may experience fewer side effects as the PET/CT-based target definition decreases the likelihood of including adjacent tissues that do not contain microscopic tumor cells in the high dose treatment volume. We're hoping that this study will encourage our colleagues to consider PET/CT fusion with IMRT for both initial staging and treatment planning for head and neck cancer patients."
-end-
For more information on radiation therapy for head and neck cancer, please visit www.rtanswers.org. To arrange an interview with Dr. Wang or for a copy of "Initial Experience of FDG-PET/CT Guided IMRT of Head and Neck Carcinoma," please contact Nick Lashinsky at nickl@astro.org, 1-800-962-7876 or 703-839-7336.

ASTRO is the largest radiation oncology society in the world, with more than 8,500 members who specialize in treating patients with radiation therapies. As the leading organization in radiation oncology, biology and physics, the Society is dedicated to the advancement of the practice of radiation oncology by promoting excellence in patient care, providing opportunities for educational and professional development, promoting research and disseminating research results and representing radiation oncology in a rapidly evolving socioeconomic healthcare environment.

American Society for Radiation Oncology

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.